Skip to main content
Equibles
KROS logo

KROS · Keros Therapeutics, Inc. · Documents

Track KROS — free

Use KROS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KROS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.08 +0.54 (+5.66%) At close · Nov 12
Russell 2000 member Rebalance outlook locked
Market Cap
$197.81M
Shares
19.62M
Volume · Nov 12 630.16K Avg daily vol (3M) 187.94K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2024
Feb 28
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $151K Net loss $152.99M Diluted EPS -$5.20
2023
Mar 3
Annual report 10-K FY2022, ended Dec 31
Annual report for FY2022
Revenue $0 Net loss $104.68M Diluted EPS -$4.15
2022
Showing 101–150 of 216 documents
Key facts CIK 1664710 CUSIP 492327101 13F (30d) 85 filings 70 filers Visit website Investor relations